Last updated: 2 months ago
BioCryst Pharmaceuticals 8-K Report: Key Updates for Investors
Explore BioCryst Pharmaceuticals, Inc.'s latest Form 8-K filed on February 24, 2025, detailing significant corporate developments crucial for investors and stakeholders.